Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
85.4M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
33.3K
-
Shares change
-
0
-
Total reported value, excl. options
-
$102K
-
Price
-
$3.05
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q4 2023
1 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q4 2023.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.3K shares
of 85.4M outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.44M shares), EcoR1 Capital, LLC (7M shares), BML Capital Management, LLC (5.46M shares), FMR LLC (5.35M shares), VANGUARD GROUP INC (4.6M shares), TANG CAPITAL MANAGEMENT LLC (4.08M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), GEODE CAPITAL MANAGEMENT, LLC (1.81M shares), STATE STREET CORP (1.63M shares), and RENAISSANCE TECHNOLOGIES LLC (1.5M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.